Evidence map›Paper›PMID 32939680›Full record

ArticleJournal of behavioral medicine2021

A prospective study of cancer-related benefit finding in uveal melanoma patients.

Kate L Herts, Alexandra Jorge-Miller, Tammy M Beran, Tara A McCannel, Joshua F Wiley, Annette L Stanton

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of behavioral medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Kate L HertsDepartment of Psychiatry, Weill Cornell Medicine, New York, NY, USA.
Alexandra Jorge-MillerDepartment of Psychology, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Tammy M BeranDepartment of Psychology, UCLA, Los Angeles, CA, USA.
Tara A McCannelDepartment of Ophthalmology and Stein Eye Institute, UCLA, Los Angeles, CA, USA.
Joshua F WileyMonash Institute for Cognitive and Clinical Neurosciences and School of Psychological Sciences, Monash University, Melbourne, Australia.
Annette L StantonDepartments of Psychology and Psychiatry/Biobehavioral Sciences, Jonsson Comprehensive Cancer Center, UCLA, 1285 Franz Hall, Box 951563, Los Angeles, CA, 90095-1563, USA. astanton@ucla.edu.
Cornell University · USDoheny Eye Institute · USMonash University · AUUCLA Health · USUCLA Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about contributors to the psychosocial impact of uveal melanoma, a rare cancer. Predictors and outcomes of benefit finding, a potentially favorable outcome, were investigated. Adults (n = 107) completed assessments prior to diagnosis of uveal melanoma and one week, three months and 12 months after diagnosis. Path analyses with the full information maximum likelihood estimation method were conducted. Objective disease impact on vision did not predict benefit finding (p > .05). Approach-oriented coping prior to diagnosis and one week later significantly predicted greater benefit finding 12 months later (p < .01). Avoidance-oriented coping at three months moderated the concurrent relationship of benefit finding and positive affect at 12 months (p < .001). This first study of predictors of benefit finding in uveal melanoma patients suggests that greater approach-oriented coping prospectively predicts higher benefit finding. Further, avoidance may condition the association of benefit finding with psychosocial outcomes.

Indexed as

MelanomaUveal NeoplasmsAdaptation, PsychologicalAdultHumansProspective StudiesUveal MelanomaBenefit findingCancerChoroidal melanomaPost-traumatic growthStress-related growthUveal melanoma

Identifiers

PMID32939680
OpenAlexW3087362945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.